Hints and tips:
Related Special Reports
...The group this year sold its stake in vaccines maker Medicago amid suggestions that its involvement was holding back the company’s progress. The business of corporate transformation can’t be rushed....
...Haleon was created with consumer health assets from GSK, Pfizer and Novartis....
...Sales at the company, one of the “Big Four” diagnostic makers worldwide, have increased in the past year on demand for its Covid-19 tests, though it does not make vaccines....
...But if this drug is approved for the condition, he said oncologists should be using the diagnostic to select patients right for the medicine....
...They developed cancer antibodies for Switzerland’s Novartis. Then BioNTech bought the plant to ramp up production of one of the handful of vaccines the world is counting on to end the pandemic....
...The facility, acquired by Germany’s BioNTech in September from Swiss pharmaceutical company Novartis, was brought online this month and will produce 250m Covid-19 vaccine doses in the first half of 2021....
...The figures are incomplete because of the fragmented nature of reporting — and the real number of infections is likely to be many times higher than the total verified by diagnostic tests....
..., diagnostics and therapies as well as harnessing its incredible genomic capacity which is being used to full effect to spot new variants of the Covid-19 virus.”...
...Germany’s BioNTech has agreed to buy a specialist production facility from Swiss pharma giant Novartis, which will allow it to deliver more than 500m additional doses of its Covid-19 vaccine next year....
...Not enough disease was around to reach a firm conclusion, and the investigators relied on a diagnostic tool not widely available in doctors’ offices....
...drugs, and diagnostics do not fail in the face of new strains....
...If anything, that is optimistic, according to Stephen Tang, chief executive of OraSure Technologies, a rival diagnostics company....
...His administration has invoked the law several times in recent months in response to the pandemic, to manufacture equipment such as ventilators and diagnostic testing equipment....
...BioNTech also acquired a manufacturing site in Marburg, Germany, in September from Swiss pharmaceutical group Novartis, which will increase its overall production capacity at some point next year....
...PCR (polymerase chain reaction) tests, the gold standard of diagnostic sensitivity, cannot provide results in real time....
...Dunoyer, AstraZeneca’s chief financial officer, told reporters on Saturday that Soliris’s “second-generation” successor Ultomiris was about 30 per cent cheaper, while Mr Soriot noted that Sanofi-Genzyme, Novartis...
...Quest Diagnostics, the largest laboratory company in the US, this week warned that there was “no way” the industry could expand molecular nasal swab testing capacity in time for the autumn, when demand is...
...Unrelated to the virus, 2021 is likely to herald advances in genome editing — an important tool in developing Covid-19 diagnostic kits and antivirus drugs, as well as new treatments for cancer and rare diseases...
...Paul Fehlner, former patent chief at Swiss drugmaker Novartis and now current chief executive of Revision Therapeutics, said pharma companies are more likely to make their drugs cheaper if there is a clear...
...Abbott’s new diagnostic test for Covid-19 could cut the wait for results down to as little as five minutes for a positive result and 13 minutes for a negative one....
...The World Health Organisation is weighing up a proposal that companies make patents treatment, vaccines and diagnostics available worldwide. That will go against the grain for the industry....
...J&J is developing a vaccine for the Covid-19 that will be available on a not-for-profit basis. If early trials deliver good results, the vaccine could be ready by early 2021....
...and diagnostics....
...With new treatments, diagnostics and vaccines slow to develop, the pandemic is a sobering reminder of the continued dominance of a disease control method unchanged since the Middle Ages: quarantine....
...Via Bloomberg: Moderna Inc. said its experimental vaccine for Covid-19 could be available to a select few as soon as this fall, ahead of expectations for a commercial release in a year....
International Edition